Illuminant’s clinical research team presented pioneering work at the American Society of Pain and Neuroscience (ASPN) 2023 Annual Conference in Miami Beach, FL. This first-of-its-kind review explores the adoption of emerging technologies—including extended reality, robotics, and endoscopy—in interventional percutaneous pain procedures. The study quantifies usage rates across technological domains, identifies the most commonly reported procedures, and evaluates the impact of these tools on patient outcomes.

Most notably, the research highlights significant barriers to widespread adoption, including cost and accessibility challenges. Illuminant’s innovative navigation platform directly addresses these gaps by offering a cost-effective, high-precision solution with a lower learning curve. By showcasing this work at ASPN, Illuminant reinforces its commitment to advancing surgical technology and expanding access to cutting-edge care.